David Morse

David Morse is an accomplished biopharmaceutical executive with over 25 years of experience in Quality, Operations, Manufacturing, and Project Management, specializing in cell therapy and biologics. Currently serving as the Head of Cell Therapy Quality at AstraZeneca, they previously held leadership positions at companies such as Appia Bio and Amgen, where they were responsible for critical quality and operations initiatives. David has demonstrated exceptional skill in team management and cross-functional collaboration, contributing to significant advancements in allogeneic cell therapy products and facilities. With a Bachelor of Science degree from the University of California at Santa Barbara, they continue to lead innovations in the biopharmaceutical field.